You are here

Congress Planner

  • Jun 2017

    The British Institute of Radiology

    This event is aimed at clinicians, especially general radiologists who encounter PET scans as part of their daily work but don’t report them in addition to trainees. The aim is to give a basic understanding of the science underpinning PET, its indications, pitfalls and superficial image interpretation. It will conclude by summarising future tracer developments and imminent new indications for PET feature. Hear from high-quality speakers with vast experience in the world of PET/CT, including those from the West of Scotland PET centre, currently one of the busiest centres in the UK.

    Educational aims:

    • To gain a basic understanding of the science behind PET
    • To discuss indications for PET referral
    • To gain a basic understanding of PET interpretation

    Registration fees
    BIR member Plan 1 �80
    BIR member Plan 2 �60
    BIR Trainee member �40
    BIR Retired/Student member �30
    Non-member Consultant or equivalent �110
    Non-member Other grades �90
    Non-member Trainee �60
    Non-member Retired/Student �50
    Glasgow, United Kingdom
  • Jul 2017
    Aug 2017


    The focus of the GI Tract, Mucosa, Microbiota, and Beyond” conference will serve as an important venue for sharing the most current scientific discoveries in GI research and for establishing new collaborations between topic areas.

    This meeting will span the entire range of investigation in gastroenterology, from molecules to cellular interactions to microbiota to intact organisms. There will be a focus on comparing and contrasting normal biology/physiology with disease pathophysiology and on providing a clinical context for basic research observations. Eight thematic sessions have been organized to encompass rapidly developing areas in GI research: a) Monitoring and Responding to the Microbiota, b) Mucosal Injury and Restitution, c) Microbiota-Host Crosstalk, d) Signaling Mechanisms Coordinating Gastrointestinal Homeostasis and Response to Inflammation, e) The Stem Cell Niche, Inflammation, and Cancer, f) Transport and Barrier, g) Host-Pathogen Interactions, and h) Novel Approaches to GI Biology. The format is designed to facilitate the rapid translation of basic biology discoveries into new medically relevant approaches to human disease.

    In addition to the platform talks from established investigators and early-career rising stars, a number of abstracts from trainees and young investigators will be selected for short talk presentations, and two poster and two oral presentation sessions of rapid-fire “ePoster” presentations will be held to maximize the number of investigators given exposure. This conference will not only provide a strong overview of cutting edge GI research but also provide a critical venue for trainees and early career investigators to showcase their work.

    Alongside the scientific sessions, the meeting will have several important career development components. “Meet-the-expert” breakfast mentoring sessions will provide small-group mentoring opportunities for junior investigators. Workshops on grant-writing and publishing featuring NIH staff, editors of major GI journals, and experienced investigators in the field are planned, adding a rich component of mentoring and development for junior trainees at the meeting.

    This conference will facilitate face-to-face interaction between investigators in multiple aspects of GI biology and disease. It will bring young researchers into contact with established investigators who can contribute to their mentoring and career development driving new collaborations and promote synergy in the field.

    Steamboat Springs, United States
  • Aug 2017
    Aug 2017

    American Academy of Anti-Aging Medicine/ Metabolic Medical Institute

    This module focuses on inflammatory disorders, autoimmune diseases, allergies, cancer & the gut-immune-brain connection. Cellular & molecular biology of immunity, the cellular stress response, oxidation, genetic damage, inflammation, etiology of disease including environmental & lifestyle factors & the risk for cancer development are reviewed. Clinical approaches to patient evaluations, testing & disease management are provided.

    Learning Objectives

    Compare integrative oncology protocols and immune nutritional support techniques

    Review the role of heavy metals, genes, environment, and biotoxic exposures in autoimmunity

    Discuss gastrointestinal manifestations of autoimmune disease

    Describe the important interactions of the endocrine system with immunity

    Recognize the intracellular signaling pathways, cellular biology, and molecular biology of immunity and inflammation

    Identify the micronutrient insufficiencies that lead to DNA and mitochondrial damage

    Las Vegas, United States
  • Sep 2017
    Sep 2017


    “Integrating science into oncology for a better patient outcome.” In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge.

    The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients.

    The ESMO Congress is the most influential annual meeting for oncology professionals in Europe. We invite you to save the date.

    Madrid, Spain
  • Sep 2017
    Sep 2017

    Prof. Dr. Nazım Şekeroğlu

    The First Japan-Turkey International Symposium on Pharmaceutical and Biomedical Sciences was organized by Kumamoto University, Kumamoto – Japan on October 2-3, 2016. This scientific organization was the first meeting of Turkish and Japanese scientists on our international collaboration and projects. In this meeting, more than twenty scientific works were presented orally or as posters. Participants of the first meeting were from Turkey, Japan, Nepal, China, Egypt, Iraq and Sudan.  

    After this successful meeting, organizing committee members from both sides, Turkish and Japanese scientists, decided to continue this valuable and fruitful scientific collaboration. Thus, “The Second Japan-Turkey International Symposium on Pharmaceutical and Biomedical Sciences, JATUSPAB-2” have been decided to be organized in Trabzon, Turkey during September 11-12, 2017.

    Although the title of the symposium covers Japan and Turkey, all scientists worldwide from all disciplines especially studying “Pharmaceutical and Biomedical”  are kindly invited to participate this valuable scientific meeting with unique social activities in Trabzon province of Turkey, where the green and blue meet.


    • Agricultural Practices of MAPs
    • AIDS/HIV Research
    • Antiretroviral Therapy (ART)
    • Aromatherapy & Phytoteraphy & Phytochemistry
    • Biology & Biochemistry & Biotechnology
    • Biodiversity
    • Biosensors and Bioelectronics
    • Botany & Ethnobotany & Ethnopharmacology
    • Conservation, Management and Sustainable Uses of MAPs & NWFPs
    • Design and Discovery of Novel Biologically Active Compounds
    • Drug Delivery System
    • Essential Oils & Secondary Plant Metabolites
    • Herbal & Traditional Medicines
    • Industrial Processing Technologies of MAPs
    • Legislations on MAPs & NWFPs
    • Literature on MAPS
    • Marketing of MAPs and Products
    • Bioorganic Medicinal Chemistry  
    • Molecular Cancer Therapeutics
    • Molecular Modeling and Simulations
    • Natural Cosmetics
    • Non-Governmental & Non-Profit Organizations (NGO & NPO) on MAP
    • Photodynamic Therapy
    • Retroviruses
    • Standardization and Quality of MAP Products
    • Traditional & Modern Herbal Products
    • Pharmacognosy
    • Phytopharmacology & Toxicology
    • Structural Biology 
    Trabzon, Turkey
  • Sep 2017
    Sep 2017


    Meet the future of ATMP commercialisation at Europe’s premier partnering event at Phacilitate’s 3rd Cell & Gene Therapy Europe. Join 400 industry decision-makers and key external stakeholders at the event which defines the strategic roadmap to European success for cell & gene therapy developers, ensuring European patients gain access to the game-changing biotherapeutics of tomorrow.

    Be a part of the only European event that offers extensive coverage of ATMP R&D, manufacturing and regulatory issues and challenges, translating innovation to global success. 

    Berlin, Germany
  • Sep 2017

    Mayo School of Continuous Professional Development

    This course will provide the latest, state-of-the-art information on the diagnosis and management of common disorders such as esophageal strictures, complications of bariatric surgery, functional GI disorders, colon cancer screening, IBD, fatty liver, Hepatitis B and C, dermatologic manifestation of various GI conditions. In addition, advances in liver transplantation and endoscopic innovations will be presented.    The intended audience includes gastroenterologists, hepatologists, primary care physicians, nurses and advanced healthcare practitioners.

    Course format will offer didactic lectures, panel discussions and interactive Q & A. Active audience participation is strongly encouraged.

    NEW THIS YEAR! Join us for an optional tour of the Proton Beam therapy facility

    Phoenix, United States
  • Oct 2017
    Oct 2017

    Cancer Science Institute of Singapore, National Univ. of Singapore

    RNA BIOLOGY has emerged as one of the most influential areas in modern biology and translational medicine. Join us at this symposium which brings together internationally renowned experts in the field of RNA Biology, with the focus on: Non-classical RNAs, RNA Editing/ Modification, RNA splicing, RNA in disease and crosstalk between RNA classes and processes.
    Join us for the third meeting of this annual symposium and find out more about exciting discoveries made in the area of RNA Biology. 

    Keynote Speakers: Prof Andrew Fire (Stanford University) and Prof Lynne Maquat (University of Rochester)
    Singapore, Singapore
  • Oct 2017
    Oct 2017

    MENA Conference

    Cancer as a disease is on the top of the health agenda of all the countries and Collective efforts, collaborations and joint forces worldwide are leading to huge developments in the areas of initial diagnosis and prevention.

    Despite global advancements, we continue to face the challenges of chronic diseases such as cancer, which according to the World Health Organization, is one of the leading causes of morbidity and mortality worldwide. In 2012, approximately 14 million new cases and 8.2 million cancer related deaths were recorded globally. This reinforces the magnitude of the problem and calls for health care institutions to focus on research, multidisciplinary treatment of the disease and a need for sustained community outreach to raise awareness about the need for regular screening and leading a healthy lifestyle.

    Following the resounding success of the 4th edition of the International Oncology Conference 2016, this year's event offers a superb opportunity for medical, surgical oncologists, pathologists, radiologists, radiation therapists and other healthcare professionals in the Gulf and the Middle East region to attend expert updates and to share best practices and experiences to discuss the latest evidence and developments in the management and treatment of various cancer diseases including breast, colon, lung, gynecological, urological and pediatric cancers.

    The program will emphasize on the theme "Navigating cancer care by early detection and prevention" to highlight the importance of screening, early diagnosis and prevention of cancer leading to successful treatment outcomes. The conference will also scope issues and challenges in this critical field in order to raise awareness and consider ways towards better care for cancer patients.

    Abu Dhabi, United Arab Emirates
  • Oct 2017
    Oct 2017

    National Healthcare Group

    Organised by The National Healthcare Group (NHG), The Singapore Health & Biomedical Congress (SHBC) is the Largest and Most Iconic Healthcare & Scientific Congress in Singapore. Over the years, it has firmly established itself as the leading Congress for the latest developments in healthcare! This year, with the restructuring of Singapore’s healthcare clusters, we are expecting close to 3,500 delegates from Singapore and the region including Australia, Japan, Korea, Russia, Sri Lanka and United Kingdom.

    SHBC 2017 provides a comprehensive and unrivalled platform for Healthcare Community Professionals consisting of Doctors, Clinicians, Nurses, Allied Health Professionals, Specialists, Medical Industry Experts, Research Scientists, and Academics. Stakeholders meet, share and network with the common goal of providing the highest quality of healthcare to patients and the community through a bustling exchange of exciting ideas, experiences and best practices among speakers and delegates.

    Singapore, Singapore


Search this site

Search form

ECCO2017 symposium webcast: Treatment evolution in advanced GI malignancies

Welcome and introduction - Florian Lordick


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Featured Content

New Book Content

This online Resource Centre has been sponsored by Lilly Oncology

Note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review.